This study explored the genetic variability in opioid receptor genes (OPRM1 and OPRD1) and their association with pain and adverse drug reactions (ADRs) in colorectal cancer patients in a Latin American Mestizo sample (Chileans). The gene discussed is OPRD1; the disease is colorectal cancer.